https://www.biospace.com/zevra-therapeutics-appoints-neil-f-mcfarlane-as-president-chief-executive-officer-and-director
Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director -...
Oct 10, 2023 - Zevra Therapeutics, Inc. today announced that Neil F. McFarlane has been named President and Chief Executive Officer of Zevra and appointed to the Board of...
https://www.biospace.com/zevra-therapeutics-announces-two-abstracts-accepted-for-presentation-at-the-19th-annual-worldsymposium-2023
Zevra Therapeutics Announces Two Abstracts Accepted for Presentation at the 19th Annual...
Feb 23, 2023 - Zevra Therapeutics, Inc. has announced that two abstracts involving clinical research of arimoclomol for the treatment of Niemann-Pick disease type C (NPC),...
https://www.fxempire.com/stocks/zvra/news
Zevra Therapeutics, Inc. Common Stock (ZVRA) Stock Forecasts & News | FXEmpire
Explore the latest news and expert analysis on Zevra Therapeutics, Inc. Common Stock (ZVRA) stock. Stay informed with in-depth forecasts, and insightful...
common stockzevratherapeuticsinczvra
https://finviz.com/news/175442/zevra-therapeutics-zvra-soars-104-is-further-upside-left-in-the-stock
Zevra Therapeutics (ZVRA) Soars 10.4%: Is Further Upside Left in the Stock?
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/zevra-therapeutics-expands-executive-leadership-team
Zevra Therapeutics Expands Executive Leadership Team - BioSpace
Jun 25, 2024 - Zevra Therapeutics, Inc. today announced the appointments of Rahsaan W. Thompson as Chief Legal Officer, Secretary and Compliance Officer, and Alison Peters as...
executive leadership teamzevratherapeuticsexpands
https://informaconnect.com/rare-disease-summit/speakers/mark-meier/
Mark Meier - Zevra Therapeutics | Rare Disease Conference 2027 - Rare Disease Summit Speaker
Connect with Key Stakeholders and Propel Curative Progress, Orphan Product Success and Patient Advocacy
mark meierrare diseaseconference 2027zevratherapeutics
https://www.fiercebiotech.com/keyword/zevra-therapeutics
Zevra Therapeutics | Fierce Biotech
zevratherapeuticsfiercebiotech
https://www.biospace.com/zevra-therapeutics-reports-first-quarter-2024-financial-results-and-corporate-updates
Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates - BioSpace
May 9, 2024 - Zevra Therapeutics, Inc., a rare disease therapeutics company, provided corporate updates and reported its financial results for the first quarter ended March...
2024 financial resultsfirst quarter
https://www.biospace.com/zevra-therapeutics-reiterates-commitment-to-rare-disease-community-as-new-corporate-council-member-of-the-national-organization-for-rare-disorders-nord
Zevra Therapeutics Reiterates Commitment to Rare Disease Community as New Corporate Council Member...
Mar 1, 2023 - Zevra Therapeutics, Inc. announced that it has become a Corporate Council member of the National Organization for Rare Disorders and reiterated its commitment...
rare disease community
https://www.home.saxo/en-sg/markets/stocks/zvra-xnas
Zevra Therapeutics Inc. stock | Saxo
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare...
zevratherapeuticsincstocksaxo
https://zevra.com/
Zevra Therapeutics - A rare approach to therapeutics.
We overcome the challenges of traditional drug development by following the data and weaving a compelling regulatory narrative that puts unmet needs of...
zevratherapeuticsrareapproach
https://zevraproject.eu/
ZEvRA – Zero Emission electric Vehicles enabled by haRmonised circulArity
zero emissionelectric vehicleszevraenabledharmonised
https://www.macrotrends.net/stocks/charts/ZVRA/zevra-therapeutics/total-share-holder-equity
Zevra Therapeutics Share Holder Equity 2014-2026 | ZVRA | MacroTrends
Zevra Therapeutics share holder equity from 2014 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
share holderzevratherapeuticsequity2014
https://www.biospace.com/zevra-therapeutics-to-report-third-quarter-2023-results-on-november-7-2023-at-8-00-a-m-et
Zevra Therapeutics to Report Third Quarter 2023 Results on November 7, 2023, at 8:00 a.m. ET -...
Oct 31, 2023 - Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics company, today announced that it will host a conference call and...
https://www.fxempire.com/stocks/zvra/advanced-chart
Zevra Therapeutics, Inc. Common Stock (ZVRA) Stock Live Chart | FXEmpire
View live Zevra Therapeutics, Inc. Common Stock stock chart to track the latest price changes. ZVRA price chart, real-time data, technical analysis tools, and...
common stocklive chartzevratherapeuticsinc
https://feverup.com/m/610548/en
Zevra Festival 2026 - Cullera - Tickets | Fever
Zevra Festival 2026 is the ultimate summer destination for urban music, reggaeton, and pop lovers, taking over the stunning coastal setting of Cullera. Get...
festival 2026zevraculleraticketsfever
https://www.home.saxo/nl-be/markets/stocks/zvra-xnas
Zevra Therapeutics Inc. aandeel | Saxo Bank
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare...
zevratherapeuticsincaandeelsaxo